Utilization of Donor CLL-1 CAR-T Cells for the Treatment of Relapsed of Acute Myeloid Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation
FRONTIERS IN IMMUNOLOGY（2025）
Key words
CLL-1,CAR-T,AML,Donor-derived,HSCT
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined